A recent systematic review identified 33 registered trials looking at GLP-1s for SUDs, predominantly for alcohol and nicotine, but with growing interest in opioid and stimulant SUDs
Ian Ellis and VoaFit Wegovy Price Drop Exposes a Bigger Problem A major shift in obesity treatment is underway following a surprising pricing move that could change how patients access care
A comparison of muscle activation between barbell bench press and dumbbell flyes in resistance-trained males
Recalls & Warnings September 18, 2012 Maker of Noni, Nopal, Blood Sugar and Cholesterol Supplements Warned For Drug Claims, Misbranding, and Manufacturing Violations On August 27, 2012, the FDA issued a warning letter to Naturavit, Inc
Meal timing matters as much as total calories
Even though Semaglutide GLP-1 injections were primarily created to help patients manage their type 2 diabetes, many doctors will prescribe it as a form of weight loss medication